One of the most important functions of skins is to protect our bodies from microbes or pollutant sources. Skins containing physical substances serve as a physical barrier which protects our bodies from pathogens. A healthy skin contains a variety of antibacterial substances such as defensin, cathelicidin and psoriasin. However deep and wide burns cause the skin to lose its original functions, so our skins are exposed to various danger factors. For the burn patients, human alloskin graft serves as a very important temporary biological wound dressing. It protects the wound before autograft procedure, forms revascularization and granulation tissues and protects the wound from an invasion of microbes. This study was conducted with the aim to analyze the antimicrobial effect of cryopreserved allograft (CPA) and glycerol-preserved allograft (GPA) which was a type of allograft widely used for burn patients, and measure the difference in comparison with the fresh skin before processing it. The most common contaminants found in burn patients such as S. aureus, P. aeruginosa, C. albicans and E. coli, were used for experiment. The antimicrobial effect against S. aureus and E. coli was observed in fresh skin and some CPA. In some clinical cases, infection is frequently observed in the wounds treated with allograft, indicating the allograft completely block every kind of microbes. To prevent the infection, it is required to use antibiotics and manage wounds thoroughly.
References
[1]
Fulton, C., Mark Anderson, G., Zasloff, M., Bull, R. and Quinn, A.G. (1997) Expression of Natural Peptide Antibiotics in Human Skin. The Lancet, 350, 1750-1751.
https://doi.org/10.1016/S0140-6736(05)63574-X
[2]
Braff, M.H., Bardan, A., Nizet, V. and Gallo, R.L. (2005) Cutaneous Defense Mechanisms by Antimicrobial Peptides. Journal of Investigative Dermatology, 125, 9-13. https://doi.org/10.1111/j.0022-202X.2004.23587.x
[3]
Montes, L.F., Black, S.H. and McBride, M.E. (1967) Bacterial Invasion of the Stratum Corneum in Erythrasma. Journal of Investigative Dermatology, 49, 474-485.
https://doi.org/10.1038/jid.1967.168
[4]
Schauber, J. and Gallo, R.L. (2009) Antimicrobial Peptides and the Skin Immune Defense System. Journal of Allergy and Clinical Immunology, 124, 13-18.
https://doi.org/10.1016/j.jaci.2009.07.014
[5]
Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E. and Schröder, J.M. (2005) Antimicrobial Psoriasin (S100A7) Protects Human Skin from Escherichia coli Infection. Nature Immunology, 6, 57-64. https://doi.org/10.1038/ni1142
[6]
Milner, S.M., Bhat, S., Buja, M., Gulati, S., Poindexter, B.J. and Bick, R.J. (2004) Expression of Human Beta Defensin 2 in Thermal Injury. Burns, 30, 649-654.
https://doi.org/10.1016/j.burns.2004.06.001
[7]
Song, W.K., Lee, K.M., Sjin, D.H. and Kim, H.T. (1999) Antimicrobial Susceptibility Patterns of Predominant Bacteria Isolated from the Burn Patients. Journal of the Korean Society for Chemotherapy, 17, 47-52.
[8]
Church, D., Elsayed, S., Reid, O., Winston, B. and Lindsay, R. (2006) Burn Wound Infections. Clinical Microbiology Reviews, 19, 403-434.
https://doi.org/10.1128/CMR.19.2.403-434.2006
[9]
Chim, H., Tan, B.H. and Song, C. (2007) Five-Year Review of Infections in a Burn Intensive Care Unit: High Incidence of Acinetobacter baumannii in a Tropical Climate. Burns, 33, 1008-1014. https://doi.org/10.1016/j.burns.2007.03.003
[10]
Hermans, M.H. (2011) Preservation Methods of Allografts and Their (Lack of) Influence on Clinical Results in Partial Thickness Burns. Burns, 37, 873-881.
https://doi.org/10.1016/j.burns.2011.01.007
[11]
Kua, E.H., Goh, C.Q., Ting, Y., Chua, A. and Song, C. (2012) Comparing the Use of Glycerol Preserved and Cryopreserved Allogenic Skin for the Treatment of Severe Burns: Differences in Clinical Outcomes and in Vitro Tissue Viability. Cell Tissue Bank, 13, 269-279. https://doi.org/10.1007/s10561-011-9254-4
[12]
Normand, J. and Karasek, M.A. (1995) A Method for the Isolation and Serial Propagation of Keratinocytes, Endothelial Cells, and Fibroblasts from a Single Punch Biopsy of Human Skin. In Vitro Cellular & Developmental Biology—Animal, 31, 447-455. https://doi.org/10.1007/BF02634257
[13]
Nasir, N.A., Halim, A.S., Singh, K.K., Dorai, A.A. and Haneef, M.N. (2010) Antibacterial Properties of Tualang Honey and Its Effect in Burn Wound Management: A Comparative Study. BMC Complementary and Alternative Medicine, 10, 31.
https://doi.org/10.1186/1472-6882-10-31
[14]
Hayashi, A., Fumon, T., Miki, Y., Sato, H., Yoshino, T. and Takahashi, K. (2013) The Evaluation of Immunohistochemical Markers and Thymic Cortical Microenvironmental Cells in Distinguishing Thymic Carcinoma from Type β3 Thymoma or Lung Squamous Cell Carcinoma. Journal of Clinical and Experimental Hematopathology, 53, 9-19. https://doi.org/10.3960/jslrt.53.9
[15]
Harder, J., Bartels, J., Christophers, E. and Schroder, J.M. (2000) Isolation and Characterization of Human Beta-Defensin-3, a Novel Human Inducible Peptide Antibiotic. Journal of Biological Chemistry, 276, 5707-5713.
https://doi.org/10.1074/jbc.M008557200
[16]
Ekrami, A. and Kalantar, E. (2007) Bacterial Infections in Burn Patients at a Burn Hospital in Iran. Indian Journal of Medical Research, 126, 541-544.
[17]
Mayhall, C.G. (2003) The Epidemiology of Burn Wound Infections: Then and Now. Clinical Infectious Diseases, 37, 543-550. https://doi.org/10.1086/376993
[18]
Unal, S., Ersoz, G., Demirkan, F., Arslan, E., Tütüncü, N. and Sari, A. (2005) Analysis of Skin-Graft Loss Due to Infection: Infection-Related Graft Loss. Annals of Plastic Surgery, 55, 102-106. https://doi.org/10.1097/01.sap.0000164531.23770.60
[19]
http://www.burn-recovery.org/skin-grafts.htm
[20]
Wood, F.M., Kolybaba, M.L. and Allen, P. (2006) The Use of Cultured Epithelial Autograft in the Treatment of Major Burn Wounds: Eleven Years of Clinical Experience. Burns, 32, 538-544.
[21]
Van Baare, J., Ligtvoet, E.E. and Middelkoop, E. (1998) Microbiological Evaluation of Glycerolized Cadaveric Donor Skin. Transplantation, 65, 966-970.
https://doi.org/10.1097/00007890-199804150-00017
[22]
Bevins, C.L. (2005) An Important Clue: Fingerprints Point to Psoriasin in Defense against E. coli. Nature Immunology, 6, 12-13. https://doi.org/10.1038/ni0105-12
[23]
Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N. and Strong, R.K. (2002) The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent That Interferes with Siderophore-Mediated Iron Acquisition. Molecular Cell, 10, 1033-1043. https://doi.org/10.1016/S1097-2765(02)00708-6
[24]
Stefanides, M.M., Copeland, C.E., Kominos, S.D. and Yee, R.B. (1976) In Vitro Penetration of Topical Antiseptics through Eschar of Burn Patients. Annals of Surgery, 183, 358-364. https://doi.org/10.1097/00000658-197604000-00005
[25]
Greenhalgh, D.G. (2009) Topical Antimicrobial Agents for Burn Wounds. Clinics in Plastic Surgery, 36, 597-606. https://doi.org/10.1016/j.cps.2009.05.011
[26]
Halim, A., Khoo, T. and Yussof, S. (2010) Biologic and Synthetic Skin Substitutes: An Overview. Indian Journal of Plastic Surgery, 43, S23-S28.
https://doi.org/10.4103/0970-0358.70712
